{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:43:29Z","timestamp":1785552209217,"version":"3.56.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Greater than 90% of patients with psoriatic arthritis (PsA) first develop their arthritis on a background of known psoriasis (Pso). Thus, having skin\/nail Pso certainly is an important risk factor for PsA but as PsA develops in &amp;lt;30% of those affected with Pso, the presence of Pso alone is insufficient as a means of identifying which patients with Pso will develop PsA. It is hoped that with further molecular assessment of Pso patients who do not have any evidence of inflammatory musculoskeletal disease compared to those with early PsA features, that the \u201cat risk\u201d profile of Pso patients destined to develop PsA can be refined such that disease prevention studies can be designed and a new era of treatment for PsA can emerge. In this article, the early stages in the development of PsA are outlined and what is currently known about clinical features, genetic factors and soluble or tissue biomarkers associated with the development of PsA in patients with Pso is reviewed in detail. Finally, proposals are outlined regarding the approaches required in order to address this important research area.<\/jats:p>","DOI":"10.3389\/fmed.2021.723944","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T07:33:55Z","timestamp":1629272035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis"],"prefix":"10.3389","volume":"8","author":[{"given":"Stephen R.","family":"Pennington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41584-021-00578-2","article-title":"Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study","volume":"17","author":"Perez-Chada","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin N Am."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab310","article-title":"Using Bayesian networks to identify musculoskeletal symptoms influencing the risk of developing psoriatic arthritis in people with psoriasis","author":"Green","year":"2021","journal-title":"Rheumatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"Br J Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10654-018-0360-5","article-title":"Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case\u2013control study","volume":"33","author":"Hedstr\u00f6m","year":"2018","journal-title":"Eur J Epidemiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.berh.2018.09.006","article-title":"Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis","volume":"32","author":"Solmaz","year":"2018","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1038\/ncomms8741","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.apcsb.2016.09.003","article-title":"Epigenetic changes in chronic inflammatory diseases","volume":"106","author":"Fogel","year":"2017","journal-title":"Adv Protein Chem Struct Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"662047","DOI":"10.3389\/fmolb.2021.662047","article-title":"The molecular pathophysiology of psoriatic arthritis-the complex interplay between genetic predisposition, epigenetics factors, and the microbiome","volume":"8","author":"Carvalho","year":"2021","journal-title":"Front Mol Biosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0212043","DOI":"10.1371\/journal.pone.0212043","article-title":"Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis","volume":"14","author":"Pollock","year":"2019","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-020-00891-x","article-title":"From psoriasis to psoriatic arthritis: insights from imaging on the transition to psoriatic arthritis and implications for arthritis prevention","volume":"22","author":"Zabotti","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ard.2007.075101","article-title":"Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study","volume":"67","author":"Gisondi","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.3899\/jrheum.110505","article-title":"Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis","volume":"38","author":"Tinazzi","year":"2011","journal-title":"J Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10067-019-04445-0","article-title":"Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years","volume":"38","author":"Elnady","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open."},{"key":"B26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two\u2013week, prospective, open-label feasibility study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ejrad.2007.08.005","article-title":"MR imaging features of foot involvement in patients with psoriasis","volume":"67","author":"Erdem","year":"2008","journal-title":"Eur J Radiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3899\/jrheum.120301","article-title":"Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms","volume":"39","author":"Emad","year":"2012","journal-title":"J Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-019-1957-0","article-title":"Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation - data from the prospective IVEPSA study","volume":"21","author":"Kampylafka","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.41239","article-title":"Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis","author":"Simon","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/1346-8138.13212","article-title":"Detection of asymptomatic enthesitis in psoriasis patients: an onset of psoriatic arthritis?","volume":"43","author":"Takata","year":"2015","journal-title":"J Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/ard.53.7.450","article-title":"Immunohistochemical markers for arthritis in psoriasis","volume":"53","author":"Veale","year":"1994","journal-title":"Ann Rheum Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/ced.12251","article-title":"Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis","volume":"39","author":"Bos","year":"2014","journal-title":"Clin Exp Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","article-title":"Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis","volume":"49","author":"Chandran","year":"2010","journal-title":"Rheumatol."},{"key":"B39","first-page":"120","article-title":"Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?","volume":"27","author":"Alenius","year":"2009","journal-title":"Clin Exp Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e46740","DOI":"10.1371\/journal.pone.0046740","article-title":"Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions","volume":"7","author":"Xue","year":"2012","journal-title":"PLoS ONE."},{"key":"B41","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3123","article-title":"Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion","volume":"12","author":"Dalbeth","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000471798","article-title":"New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions","volume":"233","author":"Li","year":"2017","journal-title":"Dermatology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"194535","DOI":"10.1155\/2015\/194535","article-title":"The assessment of selected bone and cartilage biomarkers in psoriatic patients from poland","volume":"2015","author":"Bartosi\u0144ska","year":"2015","journal-title":"Mediat Inflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0153094","DOI":"10.1371\/journal.pone.0153094","article-title":"Effect of vitamin D on peripheral blood mononuclear cells from patients with psoriasis vulgaris and psoriatic arthritis","volume":"11","author":"Cubillos","year":"2016","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","article-title":"Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis","volume":"43","author":"Kim","year":"2016","journal-title":"J Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ced.12670","article-title":"Serum IL-33 levels are increased in patients with psoriasis","volume":"41","author":"Mitsui","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1111\/ijd.13159","article-title":"Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis","volume":"55","author":"Amin","year":"2016","journal-title":"Int J Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.23298","article-title":"Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers","volume":"70","author":"Cretu","year":"2018","journal-title":"Arthritis Care Res."},{"key":"B50","first-page":"0502","article-title":"Integration of clinical and protein markers through machine learning to distinguish patients with psoriasis arthritis from those with psoriasis without psoriatic arthritis","volume":"72","author":"Rahmati","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/art.40830","article-title":"Identification of novel autoantibodies associated with psoriatic arthritis","volume":"71","author":"Yuan","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/rheumatology\/keaa405","article-title":"Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis","volume":"60","author":"Leijten","year":"2021","journal-title":"Rheumatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1559-0275-12-1","article-title":"Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers","volume":"12","author":"Cretu","year":"2015","journal-title":"Clin Proteomics."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.723944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T07:34:00Z","timestamp":1629272040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.723944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":54,"alternative-id":["10.3389\/fmed.2021.723944"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.723944","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"article-number":"723944"}}